Carol Blount is an Independent Consultant working on behalf of the ABPI. She was previously the NHS Partnership Director and still leads a team of four regional-based ABPI Partnership Managers
Carol joined the ABPI in June 2010 with more than 20 years’ senior level leadership experience within the UK pharmaceutical industry. Carol’s experience includes leadership of strategic innovation and change, business development and brand marketing.
In her new role, Carol is responsible for developing partnership working with the NHS and working with the Department of Health and NHS to support access and uptake of innovative medicines to ultimately improve patient outcomes. Carol led the ABPI input to the Innovation Health and Wealth (IHW) Report and is currently co-ordinating industry input to the IHW implementation plan. Carol is also responsible for joint working, ABPI therapy groups, Quality, Innovation, Productivity and Prevention (QIPP) and International and National uptake metrics.
Carol previously worked for Bayer and more recently for AstraZeneca where she developed her sales and marketing experience, becoming Head of Innovation prior to joining the ABPI. Carol has successfully led a number of initiatives including joint working projects with industry and primary care trusts.
Graduating from Bath University in Applied Biology, Carol began her career as a medical sales representative in the pharmaceutical industry.